“Efficiency Integrated Chemotherapy With EGFR Receptor Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer and an Activating EGFR Gene Mutation”. 2022. Voprosy Onkologii 67 (2): 246-53. https://doi.org/10.37469/0507-3758-2021-67-2-246-253.